M
Mustafa M. Husain
Researcher at University of Texas Southwestern Medical Center
Publications - 199
Citations - 13593
Mustafa M. Husain is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Electroconvulsive therapy & Major depressive disorder. The author has an hindex of 58, co-authored 195 publications receiving 12056 citations. Previous affiliations of Mustafa M. Husain include University of North Carolina at Chapel Hill & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.
A. John Rush,Mark S. George,Mark S. George,Harold A. Sackeim,Lauren B. Marangell,Mustafa M. Husain,Cole A. Giller,Ziad Nahas,Stephen J. Haines,Richard K. Simpson,Robert R. Goodman +10 more
TL;DR: These open trial results suggest that VNS has antidepressant effects in treatment-resistant depressions.
Journal ArticleDOI
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
A. John Rush,Lauren B. Marangell,Harold A. Sackeim,Mark S. George,Mark S. George,Stephen K. Brannan,Sonia M. Davis,Robert H Howland,Mitchel A. Kling,Barry R. Rittberg,William J. Burke,Mark Hyman Rapaport,John Zajecka,Andrew A. Nierenberg,Mustafa M. Husain,David Ginsberg,Robert G. Cooke +16 more
TL;DR: This study did not yield definitive evidence of short-term efficacy for adjunctive VNS in treatment-resistant depression.
Journal ArticleDOI
Vagus nerve stimulation: a new tool for brain research and therapy∗
Mark S. George,Mark S. George,Harold A. Sackeim,A. John Rush,Lauren B. Marangell,Ziad Nahas,Mustafa M. Husain,Sarah H. Lisanby,Tal Burt,J. Goldman,James C. Ballenger +10 more
TL;DR: Vagus nerve stimulation appears to be a promising new somatic intervention that may improve the understanding of brain function and has promise in the treatment of neuropsychiatric disorders.
Journal ArticleDOI
Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major Depression: A Multisite Study From the Consortium for Research in Electroconvulsive Therapy (CORE)
Charles H. Kellner,Rebecca G. Knapp,Georgios Petrides,Teresa A. Rummans,Mustafa M. Husain,Keith G. Rasmussen,Martina Mueller,Hilary J. Bernstein,Kevin C. O’Connor,Glenn E. Smith,Melanie M. Biggs,Samuel H. Bailine,Chitra Malur,Eunsil Yim,Shawn M. McClintock,Shirlene Sampson,Max Fink +16 more
TL;DR: Both C-ECT and C-Pharm were shown to be superior to a historical placebo control, but both had limited efficacy, with more than half of patients either experiencing disease relapse or dropping out of the study.
Journal ArticleDOI
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.
Georgios Petrides,Max Fink,Mustafa M. Husain,Rebecca G. Knapp,A. John Rush,Martina Mueller,Teresa A. Rummans,Kevin O'Connor,Keith G. Rasmussen,Hilary J. Bernstein,Melanie M. Biggs,Samuel H. Bailine,Charles H. Kellner +12 more
TL;DR: Bilateral ECT is effective in relieving severe major depression andRemission rates are higher and occur earlier in psychotic depressed patients than in nonpsychotic depressed patients, supporting the argument that psychotic depression is a distinguishable nosological entity that warrants separate treatment algorithms.